GLP1R and metabolic dysfunction-associated steatohepatitis: Moreover, the release of GLP-1 in vitro and in vivo is due to SCFA derived GM metabolites, and GLP-1 can stimulate dependently of the FFAR 2 the progression of steatosis to NASH, as already mentioned [15].